AVGO vs UNH: Which Is the Better Buy?
Side-by-side comparison of Broadcom Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
Broadcom Inc. · Technology
$354.99
+15.1% upside to fair value
Med Conviction
Grade B
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+28.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AVGO |
UNH |
| Current Price |
$354.99 |
$375.21 |
| Fair Value Estimate |
$408.70 |
$481.06 |
| Upside to Fair Value |
+15.1%
|
+28.2%
|
| Market Cap |
$1,688.9B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
33.0x
|
15.0x
|
| Price / Sales |
18.9x
|
0.8x
|
| Price / FCF |
42.9x
|
14.4x
|
| Revenue Growth YoY |
+85.5%
|
+0.4%
|
| Gross Margin |
67.7%
|
22.5%
|
| Operating Margin |
48.3%
|
4.8%
|
| Return on Equity |
43.9%
|
14.6%
|
| Dividend Yield |
0.73% |
2.41% |
| FCF Yield |
2.33%
|
6.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Broadcom is a diversified semiconductor and infrastructure software company led by CEO Hock Tan, with a portfolio spanning custom AI ASICs, networking, wireless, storage, and enterprise software. The business quality is high: TTM gross margin of 67.7%, TTM operating margin of 48.3%, TTM net margin of 42.9%, and ROE of 43.9% demonstrate exceptional profitability, while revenue growth of 85.5% and …
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
AVGO |
UNH |
| Zone Low |
$306.52 |
$360.80 |
| Zone High |
$347.39 |
$408.90 |
| In Buy Zone? |
No
|
Yes
|